Medifron DBT Co., Ltd. (KOSDAQ:A065650) agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. (KOSDAQ:A214270) on April 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,215 KRW | -2.21% | +2.07% | -19.01% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,215 KRW | -2.21% | +2.07% | 54.42M | ||
1,482 KRW | +1.30% | -1.85% | 91.85M | ||
1st Jan change | Capi. | |
---|---|---|
-19.01% | 54.42M | |
+16.58% | 7.02B | |
-15.79% | 1.8B | |
-5.41% | 1.27B | |
-15.33% | 1.09B | |
+5.17% | 596M | |
-33.29% | 488M | |
+19.32% | 477M | |
-53.36% | 447M | |
-32.26% | 379M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..